16/06/2026
The rapid evolution of molecular biology has ushered in an era where understanding cellular function requires more than just cataloging genetic transcripts. Researchers must now pinpoint exactly where these transcripts reside within the complex architecture of intact tissues. Traditional single-cell sequencing, while powerful, inevitably destroys this crucial spatial context during cellular dissociation. To overcome this fundamental limitation, STOmics has developed an innovative approach that integrates high-throughput genetic sequencing with high-resolution morphological mapping. At the heart of this technological breakthrough lies DNA Nanoball (DNB) technology, a revolutionary biochemical framework that redefines the limits of spatial resolution. By leveraging the unique physical properties of nanoballs, this advanced platform allows scientists to transition from bulk tissue profiling to precise subcellular analysis. Understanding the science behind this methodology is essential for researchers looking to exploit its full potential.
To appreciate the precision of this platform, one must first explore the unique molecular generation of DNA Nanoballs. Traditional sequencing technologies often rely on Polymerase Chain Reaction (PCR) to amplify genetic material. However, PCR amplification is prone to sequence-dependent bias, as certain GC-rich regions amplify more efficiently, potentially skewing quantitative results. In contrast, the synthesis of DNA Nanoballs bypasses standard PCR by utilizing a highly controlled biochemical process known as Rolling Circle Amplification (RCA).
The workflow begins with a single-stranded circular DNA template containing a Coordinate Identity Tag (CID). A highly processive phi29 DNA polymerase continuously synthesizes a complementary strand by rotating around the circular template. This rapid, linear replication yields a long, single-stranded concatemer consisting of hundreds of tandem repeats of the original circular sequence, ensuring highly efficient amplification. Due to the biophysical properties of single-stranded DNA in solution, this long molecule naturally condenses into a compact, spherical nanoball measuring approximately 220 nm in diameter. Because RCA is a linear process, every copy is synthesized directly from the original template, virtually eliminating cumulative amplification errors.
The true power of this biochemical innovation is realized when these structured nanoballs are precisely positioned on a solid capture surface. The physical foundation of the stereo-seq spatial transcriptomics solution is a silicon substrate patterned with incredible nanoscale precision using advanced photolithography. Instead of a smooth surface, the chip is designed with a dense grid of capture spots. Each patterned spot is engineered to match the exact size of a single DNA Nanoball, boasting a diameter of 220 nm}.
To ensure that the nanoballs settle perfectly into these designated positions, the platform utilizes electrostatic self-assembly. The patterned capture spots on the silicon substrate are chemically modified to carry a positive charge, while the surrounding areas of the chip remain neutral. Because DNA is naturally negatively charged due to its phosphate backbone, the synthesized nanoballs are electrostatically drawn to the positively charged spots. This charge compatibility ensures that exactly one DNB binds to each micro-patterned spot, preventing crowding. The spots are separated by a center-to-center pitch of just 500 nm.
The direct consequence of combining 220 nm capture spots with a 500 nm pitch is a quantum leap in spatial resolution. Most legacy spatial platforms use capture spots that range from 50 μm to 100 μm in diameter, which typically average the signals of dozens or even hundreds of neighboring cells. This lack of resolution can easily obscure crucial biological interfaces, such as the boundary between a tumor and invading immune cells.
By utilizing nanoscale DNB arrays, researchers can easily conduct spatial omics transcriptomics assays with genuine subcellular accuracy. To put this resolution into perspective, a standard mammalian cell has an average diameter of approximately 10 μm. On this advanced chip, a single cell of this size will physically cover up to 400 individual DNA Nanoball capture spots. Each spot acts as an independent molecular sensor, mapping the distribution of transcripts across the cell's cytoplasm and nucleus. This microscopic precision enables scientists to detect localized mRNA translation and identify rare cellular subpopulations.
Once the tissue section is mounted onto the self-assembled DNB array, the target messenger RNA molecules must be captured. Each DNA Nanoball on the chip is pre-functionalized with a molecular probe containing three essential components: a Coordinate Identity Tag (CID) that corresponds to its exact physical coordinate on the chip, a Molecular Identifier (MID) acting as a unique molecular identifier, and a poly-T tail. When the tissue is carefully permeabilized, the target messenger RNA molecules migrate vertically and hybridize perfectly with the poly-T tails of the adjacent DNBs, preventing lateral signal diffusion.
Following reverse transcription and library construction, the captured molecules are sequenced. Because the physical layout of the CIDs on the chip is pre-mapped, the downstream bioinformatics pipeline can automatically align every sequenced transcript back to its native coordinates, creating highly detailed digital gene expression maps.
In conclusion, the paradigm shift from traditional tissue profiling to high-resolution spatial mapping represents a monumental advancement in the biological sciences. By substituting standard PCR with rolling circle amplification, and replacing random surface capture with electrostatically ordered DNA Nanoballs, researchers can observe the inner workings of cells with unprecedented clarity. The resulting sub-micron resolution, combined with expansive fields of view, provides an invaluable resource for studying complex biological systems, from embryological development to human diseases. As laboratories continue to seek deeper insights into cellular microenvironments, understanding the robust biophysical principles behind these platforms will remain a key driver of scientific innovation. Through its continuous commitment to nanoscale engineering, STOmics remains a crucial leader in this analytical revolution, equipping researchers with the precise technologies needed to push the boundaries of spatial biology.